This inventor holds 1 USPTO granted patent. Top assignee: Nexstar Pharmaceuticals, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Neboisa Janjic: Innovator in Oligonucleotide Ligands
Introduction
Neboisa Janjic is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly in the development of high-affinity oligonucleotide ligands.
Latest Patents
Neboisa Janjic holds a patent for "High affinity oligonucleotide ligands to growth factors." This invention describes methods for identifying and preparing high-affinity nucleic acid ligands to TGFβ, PDGF, and hKGF. The patent includes specific RNA and ssDNA ligands to TGFβ1 and PDGF identified by the SELEX method. Additionally, it features RNA ligands that inhibit the interaction of TGFβ1 and hKGF with their receptors, as well as DNA ligands that inhibit the interaction of PDGF with its receptor. He has 1 patent to his name.
Career Highlights
Neboisa Janjic is currently associated with Nexstar Pharmaceuticals, Inc., where he continues to advance his research and innovations in the field. His work has the potential to impact therapeutic approaches significantly.
Collaborations
He has collaborated with esteemed colleagues such as Larry M Gold and Nikos C Pagratis, contributing to a rich environment of innovation and research.
Conclusion
Neboisa Janjic's work in the development of oligonucleotide ligands showcases his commitment to advancing biotechnology. His contributions are paving the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile